Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Cancer Cell|October 16, 2007
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.Cell|January 27, 2007
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stressZuzana Tothova, Ramya Kollipara, Brian J Huntly, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patientsSara Cattelani, Raffaella Defferrari, Sonia Marsilio, et al.British Journal of Cancer|June 7, 2006
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumoursS Uccini, C Colarossi, S Scarpino, et al.Medical and Pediatric Oncology|May 1, 1997
SIOP Working Committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosisG Masera, M A Chesler, M Jankovic, et al.Cancer Genetics and Cytogenetics|April 25, 2006
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumorsSimone Martinelli, Claudio Carta, Elisabetta Flex, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumorsStefania Uccini, Olga Mannarino, Heather P McDowell, et al.Journal of Hematology & Oncology|October 8, 2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cellsFrancesca Megiorni, Giovanni Luca Gravina, Simona Camero, et al.Neoplasia (New York, N.Y.)|August 21, 2012
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoformSara Cattelani, Giovanna Ferrari-Amorotti, Sara Galavotti, et al.Cancer Cell|April 9, 2008
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia veraGerlinde Wernig, Michael G Kharas, Rachel Okabe, et al.Pageof 11